Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - acetazolamide - modified-release capsule - 250mg

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

amdipharm limited - acetazolamide - modified-release capsule, hard - 250 milligram(s) - carbonic anhydrase inhibitors; acetazolamide

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - acetazolamide - capsules modified release - 250 milligram(s) - carbonic anhydrase inhibitors; acetazolamide

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - acetazolamide, quantity: 250 mg - tablet, uncoated - excipient ingredients: maize starch; calcium hydrogen phosphate dihydrate; magnesium stearate; povidone; sodium starch glycollate - for adjunctive treatment of oedema due to congestive heart failure; drug induced oedema; centrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open angle) glaucoma, secondary glaucoma and preoperatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - acetazolamide 250mg;   - tablet - 250 mg - active: acetazolamide 250mg   excipient: calcium hydrogen phosphate dihydrate magnesium stearate povidone sodium starch glycolate starch - for adjunctive treatment of: oedema due to congestive heart failure; drug induced oedema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

ABD - İngilizce - NLM (National Library of Medicine)

teva women's health, inc. - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - acetazolamide 500 mg - for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angleclosure glaucoma where delay of surgery is desired in order to lower intraocular pressure. diamox is also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent. hypersensitivity to acetazolamide or any excipients in the formulation. since acetazolamide is a sulfonamide derivative, cross sensitivity between acetazolamide, sulfonamides and other sulfonamide derivatives is possible. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. long-term administration of diamox is contraindicated in patients with chronic non-congestive angle-c

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - acetazolamide - tablet - 250 milligram(s) - carbonic anhydrase inhibitors; acetazolamide

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - acetazolamide sodium - powder for solution for injection - 500 milligram(s) - carbonic anhydrase inhibitors; acetazolamide

Malta - İngilizce - Medicines Authority

mercury pharmaceuticals limited capital house, 85 king william street, london ec4n 7bl, united kingdom - acetazolamide - tablet - acetazolamide 250 mg - ophthalmologicals

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - acetazolamide - oral tablet - 250mg